Spyre Therapeutics, Inc. - Common Stock, $0.0001 par value (SYRE)

CUSIP: 00773J202

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
+3,629,499
SEC-reported price per share
$37.93
Indexed holders
101
Value change
+$172,560,163
Number of buys
72
Number of sells
21
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
101,961,572

Security key

00773J202

Report period

Q1 2024

Indexed institutions

101

Top holders

10

Ownership snapshot

Top reported holders of SYRE - Spyre Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $56,095,732 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $56.1M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $56.1M
Venrock Adviser, LLC $51.06M
RTW INVESTMENTS, LP $48.05M
Deep Track Capital, LP $42.02M
Commodore Capital LP $40.55M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$56,095,732
2,606,679 shares
— 31 Dec 2023
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$51,060,805
2,372,714 shares
— 31 Dec 2023
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$48,048,995
2,232,760 shares
— 31 Dec 2023
Deep Track Capital, LP
13F
Company
13F
—
denominator unverified
$42,023,395
1,952,760 shares
— 31 Dec 2023
Commodore Capital LP
13F
Company
13F
—
denominator unverified
$40,545,488
1,884,084 shares
— 31 Dec 2023
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$39,578,250
1,839,138 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
101
Shares
31,640,426
Indexed holders
101
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 indexed holders
54
Q1 2024 indexed holders
101
Indexed holder difference
47
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .